Nasdaq: MIRM
Mirum Pharmaceuticals insiders
The officers, directors and 10% owners of Mirum Pharmaceuticals, Inc. who hold the most stock, valued at the live MIRM price.
$95.51
MIRM today +$3.0M (+3.27%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 7
- Their MIRM stock
- $300M
- Market value
- $6.24B
- Held by ranked insiders
- 4.81%
Insiders by value of MIRM holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | New Enterprise Associates 16, L.P. | 10% owner | 2,186,243 | $209M | 3.35% | Corporate |
| 2 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 394,137 | $37.6M | 0.60% | 2840th |
| 3 | Michael G. Grey | Director | 280,160 | $26.8M | 0.43% | 4100th |
| 4 | Lara Longpre | CHIEF DEVELOPMENT OFFICER | 104,407 | $10.0M | 0.16% | 8804th |
| 5 | Pamela Vig | CHIEF SCIENTIFIC OFFICER | 102,406 | $9.8M | 0.16% | 8942nd |
| 6 | Peter Radovich | PRESIDENT AND COO | 57,260 | $5.5M | <0.1% | 13606th |
| 7 | Scott D. Sandell | 10% owner | 12,966 | $1.2M | <0.1% | 1774th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Mirum Pharmaceuticals; see each profile for the filing.